Amit Patel, MD
Urology · Hinsdale, ILNPI 1437324084
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 54 manufacturers reported payments, led by Angiodynamics, Inc. at 57.8% of the total. Among urology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 518 payments — averaging $239.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$72K
- Intuitive Surgical$12K
- Johnson & Johnson$11K
- AbbVie$5K
- Ferring Pharmaceuticals Inc.$5K
- KARL Storz Endoscopy-america$4K
- plus $15K from 48 others
Across 59 payments — averaging $7664.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$210K
- Janssen Research & Development, LLC$153K
- Sumitomo Pharma America, Inc.$89K
What the payments were for
- Consulting fees$73,72359%
- Speaking & faculty fees$10,6659%
- Travel & lodging$13,67511%
- Food & beverage$16,91314%
- Education$8,7727%
- Gifts$2000%
- Entertainment$930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nanoknife$70,429
- Da Vinci Surgical System$11,206
- Lupron Depot$4,500
- ADSTILADRIN$4,430
- N/A$3,960
- TALZENNA$1,890
- IMFINZI$1,688
- Bulkamid$469
- Axonics$439
- iTIND System$354
- LYNPARZA$211
- JELMYTO$140
- UroLift System$134
- REVI$134
- ORGOVYX$129
- Fluid Systems - Infusion Systems$117
- HD-VIEW$115
- XTANDI$111
- AQUABEAM SYSTEM$107
- SpaceOAR VUE System - 10mL$106
How this compares
$124,041 in reported general payments places this provider in the 95th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 46 | $455,600 |
| OrgovyxRelugolix | 105 | $287,698 |
| ErleadaApalutamide | 18 | $265,731 |
| MyrbetriqMirabegron | 45 | $49,240 |
| GemtesaVibegron | 62 | $44,702 |
| Tamsulosin Hcl | 606 | $10,146 |
| Testosterone | 35 | $8,512 |
| Methenamine Hippurate | 79 | $7,108 |
| Finasteride | 495 | $6,387 |
| Dutasteride | 99 | $3,256 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 126 | $2,886 |
| Trospium Chloride | 43 | $2,841 |
| Potassium Citrate ErPotassium Citrate | 36 | $2,701 |
| Tadalafil | 25 | $2,512 |
| Testosterone Cypionate | 61 | $1,932 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $1,688 | $504,84091 claims |
| Sumitomo Pharma America, Inc.Orgovyx, Gemtesa | $491 | $332,400167 claims |
| Johnson & JohnsonErleada | $11,242 | $265,73118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 550 urology providers in Illinois.
Other urology in Hinsdale
- Mark BrandtPark Ridge$1.3M
- Aaron BergerChicago Ridge$583K
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Kevin McVarySpringfield$372K
- Richard HarrisMelrose Park$363K
- Amy KrambeckChicago$356K
- Kevin ZornChicago$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.